| Oct 17 |
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
|
| Oct 16 |
Novartis to appeal latest setback to stopping Entresto generics
|
| Oct 16 |
Bayer Seeks Approval for Elinzanetant for Vasomotor Symptoms in EU
|
| Oct 16 |
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
| Oct 15 |
Novartis (NVS) Upgraded to Buy: Here's Why
|
| Oct 14 |
Novartis ends development of phase 2 idiopathic pulmonary fibrosis asset
|
| Oct 14 |
2 Magnificent Dividend Stocks to Buy and Hold Forever
|
| Oct 9 |
LLY, NVS, or ISRG: Which Healthcare Stock Scores Wall Street’s “Strong Buy” Rating?
|
| Oct 9 |
5 Low-Leverage Stocks to Buy Buoyed by Impressive Tech Earnings
|
| Oct 7 |
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
